Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
WuXi STA Begins Pharmaceutical Manufacturing Facility Construction in USA
WuXi STA has begun construction of a new 190acre pharmaceutical manufacturing campus in Middletown, Delaware, in the United States This location will be WuXi STAs second in the country, providing increased flexibility and capacity to meet the demands of clients in the US and beyond
Catalent Invests US$ 2.2 million for Clinical Supply Facility in Singapore
Catalent invested US$22 million for the expansion of its clinical supply facilities in Singapore The investment will allow the installation of 35 new freezers for ultralow temperature ULT storage, expanding the sites footprint by over 20 to 31,000 square feet
Merck Invests more than US$130 million for Manufacturing Facility Expansion in France
Merck has invested more than US$130 million to improve its production capabilities for singleuse assemblies in Molsheim, France The expansion will boost production capabilities for singleuse assemblies from the Mobius portfolio
First North American Biomanufacturing Facility Opened in USA by WuXi Biologics
WuXi Biologics opened MFG18, its first GMP phase I drug substance clinical production facility, in Cranbury, New Jersey, USA With solely singleuse technology, the 154,448 square foot sites operational capacity for clinical manufacture will increase to 6,000 litres from its initial capacity of 4,000 litres
Horizon Therapeutics to Expand its Development, Manufacturing Facility in Ireland
Horizon Therapeutics plans to increase the size of its manufacturing and development facility in Waterford, Ireland The facility will increase the companys current 44,000 square foot drug product fillfinish biologics facility by about 320,000 square feet
Thermo Fisher Completes Expansion of its Cell Culture Media Site in USA
Thermo Fisher Scientific has finished the expansion of one of its manufacturing facilities for cell culture media, in Grand Island, New York, in the United States
Merck Invests $470 million in Expanding Membrane and Filtration Capability in Ireland
Merck is investing about $470 million in Ireland to increase its membrane and filtering production capabilities The company will expand membrane manufacturing capacity at its existing Carrigtwohill factory and construct a new manufacturing facility
Vertex to Expand Cell, Gene Therapy R&D Center in Boston
With a new lab facility near the Seaport, Vertex Pharmaceuticals is increasing its footprint in Boston The 344,000 square foot extension will support Vertexs development strategy and expansion and will be a significant step forward in the companys RD and manufacturing
Catalent Invests US $175 million in a New Manufacturing Facility in Winchester
Catalent has invested $175 million to develop its flagship US manufacturing plant for largescale oral dose form in Winchester, Kentucky The project, which is planned to open in January 2024, will increase the production footprint of the site by 107,07,000 square feet
BeiGene Opens New Manufacturing Facility in New Jersey
BeiGene plans to open new manufacturing site and RD center for the development of advanced new medicines The new stateoftheart manufacturing site is laid in 42acre site The initial phase of the construction is designed with several hundred
